|
1) 日本呼吸器学会COPDガイドライン作成委員会, 編. COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン第3版―日本呼吸器学会COPDガイドライン. 東京: メディカルレビュー社; 2009
|
|
|
|
|
2) NHLBI/WHO Workshop Report. Global Initiative for Chronic Obstructive Lung Disease –global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated 2006
|
|
|
|
|
|
3) Kanai F, Marignani PA, Sarbassova D, et al. A novel transcriptional co-activator regulated by interactions with 14-3-3 and pdz domain proteins. The EMBO J. 2000; 19: 6778-91
|
|
|
|
|
4) Murakami M, Tominaga J, Makita R, et al. Transcriptional activity of pax3 is co-activated by taz. Biochem Biophys Res Commun. 2006; 339: 533-9
|
|
|
|
|
|
5) Makita R, Uchijima Y, Nishiyama K, et al. Renal tubular dysmorphogenesis leading to multicystic formation and lung emphysema in mice lacking TAZ. Am J Physiol. 2008; 294: F542-53
|
|
|
|
|
|
6) Mitani A, Nagase T, Fukuchi K, et al. Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. Am J Respir Crit Care Med. 2009; 180: 326-38
|
|
|
|
|